UHRF2通过PI3K/Akt信号通路促进肝细胞癌细胞的增殖和转移

程凤娟; 孙菁婕; 方娴韵; 陈思圜; 刘尚静; 吴可佳; 李招娣; 蒋世铭; 陈勇; 段昌柱

doi:10.16016/j.1000-5404.202002072

您当前的位置：

首页 >

文章列表页 >

UHRF2通过PI3K/Akt信号通路促进肝细胞癌细胞的增殖和转移

基础医学 | 更新时间：2026-01-09

- UHRF2通过PI3K/Akt信号通路促进肝细胞癌细胞的增殖和转移
- UHRF2 promotes migration and proliferation of human hepatocellular carcinoma cells by PI3K/Akt signaling pathway
- 第三军医大学学报 2020年42卷第13期页码：1323-1330, 1344
- 作者机构：
  
  1.400016 重庆, 重庆医科大学基础医学院细胞生物学与遗传学教研室, 分子医学与肿瘤研究中心, 400016
  2.400016 重庆, 重庆医科大学附属第一医院肝胆外科
- 作者简介：
  
  [ 段昌柱，E-mail: duanchzhu@cqmu.edu.cn DUAN Changzhu, E-mail:duanchzhu@cqmu.edu.cn
- 基金信息：
  
  国家自然科学基金面上项目(81772178)
- DOI：10.16016/j.1000-5404.202002072
  中图分类号： R394.3;R730.23;R735.7
- 收稿：2020-02-13，
  
  修回：2020-02-18，
  
  纸质出版：2020-07-15
- 稿件说明：
移动端阅览
程凤娟, 孙菁婕, 方娴韵, 等. UHRF2通过PI3K/Akt信号通路促进肝细胞癌细胞的增殖和转移[J]. 第三军医大学学报, 2020,42(13):1323-1330, 1344.

Fengjuan CHENG, Jingjie SUN, Xianyun FANG, et al. UHRF2 promotes migration and proliferation of human hepatocellular carcinoma cells by PI3K/Akt signaling pathway[J]. Journal of Third Military Medical University, 2020, 42(13): 1323-1330, 1344.
程凤娟, 孙菁婕, 方娴韵, 等. UHRF2通过PI3K/Akt信号通路促进肝细胞癌细胞的增殖和转移[J]. 第三军医大学学报, 2020,42(13):1323-1330, 1344. DOI： 10.16016/j.1000-5404.202002072.

Fengjuan CHENG, Jingjie SUN, Xianyun FANG, et al. UHRF2 promotes migration and proliferation of human hepatocellular carcinoma cells by PI3K/Akt signaling pathway[J]. Journal of Third Military Medical University, 2020, 42(13): 1323-1330, 1344. DOI： 10.16016/j.1000-5404.202002072.

摘要

目的

探讨泛素样含PHD和环指域蛋白2(ubiquitin-like with PHD and RING finger domains 2，UHRF2)在肝细胞癌(hepatocellular carcinoma，HCC)增殖和转移中的作用及其机制。

方法

检索TCGA数据库中HCC的基因表达谱数据和患者的临床数据，分析UHRF2的表达差异与HCC患者的预后情况，采用Cox比例风险模型探索UHRF2对HCC患者预后的独立作用；收集2018年7月至2019年12月在重庆医科大学附属第一医院确诊的20例肝癌患者的肿瘤组织和癌旁组织，采用免疫组化检测UHRF2蛋白的表达，分析蛋白的表达与患者临床病理参数的关系；构建UHRF2表达质粒，通过RT-qPCR和Western blot检测转染效率，在HCC细胞系中过表达UHRF2进行划痕及平板克隆实验检测肝细胞癌细胞的迁移和增殖情况；基因富集分析探讨UHRF2与PI3K/Akt通路活化的关系，Western blot检测Akt、PI3K、p-Akt、p-PI3K的表达。

结果

TCGA数据库分析显示UHRF2 mRNA在HCC组织中表达明显升高并提示预后不良；Cox多因素回归分析发现UHRF2的表达是影响患者预后的独立危险因素。免疫组化检测结果显示UHRF2蛋白在HCC中的表达明显高于癌旁组织。UHRF2的高表达与肿瘤大小(

=0.002)、肿瘤转移(

=0.002)密切相关。在迁移实验和平板克隆实验中，UHRF2过表达组的划痕愈合能力及增殖能力较对照组显著增

强(

0.01)；PI3K/Akt通路在UHRF2高表达HCC患者中显著富集；Western blot检测结果显示，UHRF2过表达组的p-Akt、p-PI3K的表达水平明显上调(

0.05)。

结论

UHRF2的表达水平与HCC的预后密切相关，是影响患者预后的独立危险因素；过表达UHRF2通过PI3K/Akt信号通路促进HCC细胞的增殖和转移。

Abstract

Objective

To explore the role of Ubiquitin-like with PHD and RING finger domains 2 (UHRF2) on the migration and proliferation of human hepatocellular carcinoma (HCC) cells and investigate its underlying mechanism.

Methods

The HCC gene expression data and patient clinical data were searched in the TCGA database

the differences of UHRF2 expression were analyzed between normal liver tissue and HCC tissue

and the correlation of its level with prognosis was also analyzed. Liver tumor tissues and adjacent normal tissues were harvested from 20 HCC patients diagnosed in the First Affiliated Hospital of Chongqing Medical University between July

2008 and December

2013 to detect UHRF2 expression by immunohistochemistry. The relationship between UHRF2 expression and clinical pathological parameters of these patients was analyzed. After UHRF2 expression plasmid was constructed and transfected into HepG2 and HepG2.2.15 cells

the transfection efficiency was measured by RT-qPCR and Western blotting. Then cell scratch test and plate cloning was employed to detect the effect of UHRF2 overexpression on the migration and proliferation of the cells. Gene set enrichment analysis was applied to further explore the relationship between UHRF2 and activation of PI3K/Akt signaling pathway. The expression of Akt

PI3K

p-Akt and p-PI3K was detected with Western blotting.

Results

TCGA database analysis revealed that the expression of UHRF2 in HCC tissues was higher than that in normal liver tissues

and indicated a poor prognosis. Cox multivariate regression analysis found that UHRF2 expression was an independent risk factor

for the prognosis. Immunohistochemistry showed that the expression level of UHRF2 was significantly higher in the HCC tissues than that in the adjacent normal tissues. The high expression of UHRF2 was closely related to tumor size (

=0.002) and tumor metastasis (

=0.002). In wound healing test and plate cloning test

the HCC cells with UHRF2 overexpression showed significantly stronger migration and proliferation abilities as compared with the control cells. PI3K/Akt pathway was significantly enriched in the HCC patients with higher expression of UHRF2. Western blotting results showed that UHRF2 overexpression significantly activated the phosphorylation of PI3K and Akt proteins in the HCC cells.

Conclusion

The expression of UHRF2 is closely related to the prognosis of HCC patients

and is an independent risk factor for HCC patients. Overexpression of UHRF2 promotes the proliferation and metastasis of HCC cells through the PI3K/Akt signaling pathway.

关键词

Keywords

references

BRAY F, FERLAY J, SOERJOMATARAM I, et al . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J ] . CA Cancer J Clin, 2018, 68(6): 394-424. DOI:10.3322/caac.21492.

HAN L L. Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy[J]. World J Gastroenterol, 2014, 20(30): 10249-10261. DOI:10.3748/wjg.v20.i30.10249.

KAMP W M, SELLERS C M, STEIN S, et al . Impact of direct acting antivirals on survival in patients with chronic hepatitis C and hepatocellular carcinoma[J ] . Sci Rep, 2019, 9(1): 1-8. DOI:10.1038/s41598-019-53051-2.

OSAKI Y, NISHIKAWA H. Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review[J]. Hepatol Res, 2015, 45(1): 59-74. DOI:10.1111/hepr.12378.

SANCHEZ-FERNANDEZ C, LORDA-DIEZ C I, GARCÍA-PORRERO J A, et al . UHRF genes regulate programmed interdigital tissue regression and ch ondrogenesis in the embryonic limb[J ] . Cell Death Dis, 2019, 10(5): 347. DOI:10.1038/s41419-019-1575-4.

WANG F, ZHANG P, MA Y L, et al . NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by let-7a microRNA[J ] . Cancer Lett, 2012, 314(2): 223-231. DOI:10.1016/j.canlet.2011.09.033.

CHEN X R, SUN S C, TENG S W, et al . Uhrf2 deletion impairs the formation of hippocampus-dependent memory by changing the structure of the dentate gyrus[J ] . Brain Struct Funct, 2018, 223(2): 609-618. DOI:10.1007/s00429-017-1512-1.

LUO T, CUI S J, BIAN C J, et al . Uhrf2 is important for DNA damage response in vascular smooth muscle cells[J ] . Biochem Biophys Res Commun, 2013, 441(1): 65-70. DOI:10.1016/j.bbrc.2013.10.018.

LU H R, HALLSTROM T C. The nuclear protein UHRF2 is a direct target of the transcription factor E2F1 in the induction of apoptosis[J]. J Biol Chem, 2013, 288(33): 23833-23843. DOI:10.1074/jbc.m112.447276.

ZENG S Y, WANG Y Y, ZHANG T, et al . E3 ligase UHRF2 stabilizes the acetyltransferase TIP60 and regulates H3K9ac and H3K14ac via RING finger domain[J ] . Protein Cell, 2017, 8(3): 202-218. DOI:10.1007/s13238-016-0324-z.

CHEN W B, WU M H, HANG T R, et al . Structure insights into the molecular mechanism of the interaction between UHRF2 and PCNA[J ] . Biochem Biophys Res Commun, 2017, 494(3/4): 575-580. DOI:10.1016/j.bbrc.2017.09.102.

金芳敏, 钱冠华, 杨艳, 等.人NIRF蛋白与HBV核心蛋白相互作用的初步研究[J].生命科学研究, 2011, 15(1): 1-5.DOI:10.16605/j.cnki.1007-7847.2011.01.001.

JIN F M, QIAN G H, YANG Y, et al . Preliminary study on the interaction between human NIRF protein and HBV core protein[J ] . Life Sci Res, 2011, 15(1): 1-5. DOI:10.16605/j.cnki.1007-7847.2011.01.001.

WANG Y Y, YAN X K, ZENG S Y, et al . UHRF2 promotes DNA damage response by decreasing p21 via RING finger domain[J ] . Biotechnol Lett, 2018, 40(8): 1181-1188. DOI:10.1007/s10529-018-2577-5.

PENG R, HUANG X Y, ZHANG C, et al . Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance[J ] . Oncotargets Ther, 2017, 10: 5863-5872. DOI:10.2147/ott.s149361.

JIN C, XIONG D, LI H R, et al . Loss of UHRF2 is associated with non-small celllung carcinoma progression[J ] . J Cancer, 2018, 9(17): 2994-3005. DOI:10.7150/jca.25876.

IGUCHI T, UEDA M, MASUDA T, et al . Identification of UHRF2 as a negative regulator of epithelial-mesenchymal transition and its clinical significance in esophageal squamous cell carcinoma[J ] . Oncology, 2018, 95(3): 179-187. DOI:10.1159/000488860.

YANG S X, POLLEY E, LIPKOWITZ S. New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancer[J]. Cancer Treat Rev, 2016, 45: 87-96. DOI:10.1016/j.ctrv.2016.03.004.

AKKOÇ Y, BERRAK Ö, ARıSAN E D, et al . Inhibition of PI3K signaling triggered apoptotic potential of curcumin which is hindered by Bcl-2 through activation of autophagy in MCF-7 cells[J ] . Biomedecine Pharmacother, 2015, 71: 161-171. DOI:10.1016/j.biopha.2015.02.029.

REDDY D, KUMAVATH R, TAN T Z, et al . Peruvoside targets apoptosis and autophagy through MAPK Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways in human cancers[J ] . Life Sci, 2020, 241: 117147. DOI:10.1016/j.lfs.2019.117147.

FU X, WEN H Q, JING L, et al . MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway[J ] . Cancer Sci, 2017, 108(4): 620-631. DOI:10.1111/cas.13177.

MOHAMED E A, AHMED H I, ZAKY H S. Protective effect of irbesartan against doxorubicin-induced nephrotoxicity in rats: implication of AMPK, PI3K/Akt, and mTOR signaling pathways[J]. Can J Physiol Pharmacol, 2018, 96(12): 1209-1217. DOI:10.1139/cjpp-2018-0259.

HOROWITZ J C, OSTERHOLZER J J, MARAZIOTI A, et al . "Scar-cinoma": viewing the fibrotic lung mesenchymal cell in the context of cancer biology[J ] . Eur Respir J, 2016, 47(6): 1842-1854. DOI:10.1183/13993003.01201-2015.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

谷胱甘肽过氧化物酶7通过PI3K-AKT通路调控肝癌细胞增殖和衰老

骨髓间充质干细胞外泌体调控肾癌细胞胆固醇代谢及其增殖、侵袭和迁移

miR-3934-5p靶向抑制β内酰胺酶表达促进肝癌细胞增殖

胎盘间充质干细胞外泌体对高糖培养的成纤维细胞衰老的影响

环指蛋白14通过抑制HNF1α促进肝癌细胞增殖与侵袭转移